Christopher D. Huston

5.3k total citations · 1 hit paper
68 papers, 2.5k citations indexed

About

Christopher D. Huston is a scholar working on Parasitology, Infectious Diseases and Surgery. According to data from OpenAlex, Christopher D. Huston has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Parasitology, 42 papers in Infectious Diseases and 26 papers in Surgery. Recurrent topics in Christopher D. Huston's work include Parasitic Infections and Diagnostics (41 papers), Amoebic Infections and Treatments (39 papers) and Diagnosis and treatment of tuberculosis (13 papers). Christopher D. Huston is often cited by papers focused on Parasitic Infections and Diagnostics (41 papers), Amoebic Infections and Treatments (39 papers) and Diagnosis and treatment of tuberculosis (13 papers). Christopher D. Huston collaborates with scholars based in United States, Japan and Switzerland. Christopher D. Huston's co-authors include William A. Petri, Eric R. Houpt, Rashidul Haque, Molly A. Hughes, José E. Teixeira, Barbara J. Mann, Adam Sateriale, Kovi Bessoff, Douglas R. Boettner and Rajiv S. Jumani and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Christopher D. Huston

65 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amebiasis

2003 544 citations Christopher D. Huston, William A. Petri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher D. Huston United States	28	1.8k	1.3k	905	370	286	68	2.5k
Sharon L. Reed United States	39	2.3k 1.3×	1.8k 1.4×	1.1k 1.2×	793 2.1×	761 2.7×	104	4.1k
Leonard N. Slater United States	25	1.5k 0.8×	1.7k 1.4×	206 0.2×	93 0.3×	336 1.2×	46	2.6k
David M. Lyerly United States	44	4.7k 2.6×	529 0.4×	1.1k 1.2×	867 2.3×	1.7k 5.9×	94	5.8k
Alain Bonnin France	30	1.9k 1.1×	656 0.5×	196 0.2×	252 0.7×	1.3k 4.5×	86	2.9k
Pia Hartmann Germany	26	562 0.3×	306 0.2×	127 0.1×	325 0.9×	651 2.3×	76	1.9k
Charles A. Scanga United States	30	2.5k 1.4×	386 0.3×	695 0.8×	648 1.8×	2.1k 7.3×	66	4.4k
Devendra Bansal Qatar	21	449 0.3×	273 0.2×	202 0.2×	202 0.5×	266 0.9×	70	1.3k
Liisa Jokipii Finland	24	726 0.4×	737 0.6×	159 0.2×	85 0.2×	305 1.1×	67	1.7k
Rodrigo Ribeiro‐Rodrigues Brazil	22	898 0.5×	385 0.3×	214 0.2×	137 0.4×	630 2.2×	56	1.5k
G Wiedermann Austria	28	659 0.4×	351 0.3×	192 0.2×	386 1.0×	692 2.4×	156	2.3k

Countries citing papers authored by Christopher D. Huston

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Huston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Huston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Huston more than expected).

Fields of papers citing papers by Christopher D. Huston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Huston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Huston. The network helps show where Christopher D. Huston may publish in the future.

Co-authorship network of co-authors of Christopher D. Huston

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Huston. A scholar is included among the top collaborators of Christopher D. Huston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Huston. Christopher D. Huston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teixeira, José E., et al.. (2025). A propidium iodide-based in vitro screen of the “Bug Box” against Babesia duncani reveals potent inhibitors. Antimicrobial Agents and Chemotherapy. 69(7). e0003525–e0003525.

Miller, Peter G., et al.. (2025). Organoid-based in vitro system and reporter for the study of Cryptosporidium parvum sexual reproduction. Microbiology Spectrum. 13(8). e0050225–e0050225.

Jumani, Rajiv S., et al.. (2024). Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiation. PLoS Pathogens. 20(4). e1011906–e1011906. 2 indexed citations

Miller, Peter G., et al.. (2024). Discovery of an Orally Efficacious Pyrazolo[3,4-d]pyrimidine Benzoxaborole as a Potent Inhibitor of Cryptosporidium. Journal of Medicinal Chemistry. 68(1). 832–849. 2 indexed citations

Miller, Peter G., Erin E. Stebbins, Scott Campbell, et al.. (2024). Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice. Nature Communications. 15(1). 8272–8272. 5 indexed citations

Patel, Radhika A., et al.. (2023). Structure-Activity relationships of replacements for the triazolopyridazine of Anti-Cryptosporidium lead SLU-2633. Bioorganic & Medicinal Chemistry. 86. 117295–117295. 5 indexed citations

Peek, H. W., Erin E. Stebbins, Peter G. Miller, et al.. (2023). Structure–Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Cryptosporidium Reveals Remarkable Role of Fluorine. Journal of Medicinal Chemistry. 66(12). 7834–7848. 6 indexed citations

Stebbins, Erin E., Robert K. M. Choy, J. Robert Gillespie, et al.. (2021). Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection. Antimicrobial Agents and Chemotherapy. 65(6). 16 indexed citations

Whitman, Timothy J., Andrew J. Hale, Devika Singh, et al.. (2021). Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre. BMJ Open Quality. 10(1). e001248–e001248. 2 indexed citations

10.

Stebbins, Erin E., Peter G. Miller, Scott Campbell, et al.. (2021). Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin. Journal of Medicinal Chemistry. 64(15). 11729–11745. 13 indexed citations

11.

Teixeira, José E., et al.. (2020). Coactosin Phosphorylation Controls Entamoeba histolytica Cell Membrane Protrusions and Cell Motility. mBio. 11(4). 5 indexed citations

12.

Bruce, Emily A., Meei‐Li Huang, Garrett A. Perchetti, et al.. (2020). Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step. PLoS Biology. 18(10). e3000896–e3000896. 117 indexed citations

13.

Jumani, Rajiv S., Erin E. Stebbins, Peter G. Miller, et al.. (2019). A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors. Nature Communications. 10(1). 1862–1862. 29 indexed citations

14.

Lunde, Christopher S., Erin E. Stebbins, Rajiv S. Jumani, et al.. (2019). Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nature Communications. 10(1). 2816–2816. 44 indexed citations

15.

Teixeira, José E., et al.. (2018). Invadosome-Mediated Human Extracellular Matrix Degradation by Entamoeba histolytica. Infection and Immunity. 86(9). 13 indexed citations

16.

Jumani, Rajiv S., Kovi Bessoff, Melissa S. Love, et al.. (2018). A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box. Antimicrobial Agents and Chemotherapy. 62(4). 44 indexed citations

17.

Stebbins, Erin E., Rajiv S. Jumani, John Barlow, et al.. (2018). Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model. PLoS neglected tropical diseases. 12(1). e0006183–e0006183. 22 indexed citations

18.

Jain, Vitul, M. Yogavel, Haruhisa Kikuchi, et al.. (2017). Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. Structure. 25(10). 1495–1505.e6. 70 indexed citations

19.

Teixeira, José E. & Christopher D. Huston. (2008). Evidence of a Continuous Endoplasmic Reticulum in the Protozoan Parasite Entamoeba histolytica. Eukaryotic Cell. 7(7). 1222–1226. 31 indexed citations

20.

Okada, Mami, Christopher D. Huston, Barbara J. Mann, et al.. (2005). Proteomic Analysis of Phagocytosis in the Enteric Protozoan Parasite Entamoeba histolytica. Eukaryotic Cell. 4(4). 827–831. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact